• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Down 2%; Alphabet Posts Upbeat Earnings

    7/24/24 10:17:19 AM ET
    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties
    Health Care
    Get the next $AZTR alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones dipping around 400 points on Wednesday.

    Following the market opening Wednesday, the Dow traded down 0.99% to 39,957.30 while the NASDAQ fell 2.08% to 17,622.81. The S&P 500 also fell, dropping, 1.47% to 5,473.80.

    Check This Out: Jim Cramer Calls Axsome A ‘Double Or Nothing Stock,’ Says SAP Is ‘Incredible’

    Leading and Lagging Sectors

    Utilities shares jumped by 0.3% on Wednesday.

    In trading on Wednesday, consumer discretionary shares fell by 2.7%.

    Top Headline

    Alphabet Inc (NASDAQ:GOOG) posted better-than-expected earnings and sales results for its second quarter.

    Alphabet reported second-quarter revenue of $84.742 billion, beating the consensus estimate of $84.202 billion. The tech giant reported quarterly earnings of $1.89 per share, beating analyst estimates of $1.85 per share, according to data from Benzinga Pro.

    Equities Trading UP
                           

    • NuZee, Inc. (NASDAQ:NUZE) shares shot up 230% to $3.37.
    • Shares of Dermata Therapeutics, Inc. (NASDAQ:DRMA) got a boost, surging 202% to $3.93 after falling over 22% on Tuesday.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares were also up, gaining 110% to $2.61.

    Equities Trading DOWN

    • Azitra, Inc. (NYSE:AZTR) shares dropped 75% to $1.23 after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.
    • Shares of Nuwellis, Inc. (NASDAQ:NUWE) were down 42% to $2.3995 after the company announced the pricing of a $2 million public offering of 469,340 common shares at $4.24 a share.
    • Vintage Wine Estates, Inc. (NASDAQ:VWE) was down, falling 33% to $0.0775 after the company announces bankruptcy filing and voluntary delisting and SEC deregistration.

    Also Check This Out: Top 3 Tech And Telecom Stocks That Are Set To Fly In July

    Commodities

    In commodity news, oil traded up 0.9% to $77.66 while gold traded up 0.7% at $2,424.60.

    Silver traded up 0.6% to $29.51 on Wednesday, while copper fell 0.6% to $4.1370.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 0.3%, Germany's DAX fell 0.8% and France's CAC 40 fell 0.8%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 rose 0.1%.

    The HCOB Eurozone manufacturing PMI declined to 45.6 in July from 45.8 in June, while services PMI slipped to 51.9 from 52.8. The HCOB France composite PMI climbed to 49.5 in July from 48.8 in the prior month, while German composite PMI declined to 48.7 from 50.4.

    The S&P Global Flash UK manufacturing PMI rose to 51.8 in July from 50.9 in June, while services PMI rose to 52.4 in July from 52.1 in the previous month.

    Asia Pacific Markets

    Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.11%, Hong Kong's Hang Seng Index falling 0.91%, China's Shanghai Composite Index declining 0.46% and India's S&P BSE Sensex declining 0.35%.

    The HSBC India Manufacturing PMI climbed to 58.5 in July from 58.3 the prior month, while services PMI rose to 61.1 in July from 60.5. The au Jibun Bank Flash Japan composite PMI rose to 52.6 in July versus a final reading of 49.7 in June.

    Economics

    • U.S. mortgage applications declined by 2.2% in the latest week, compared to a 3.9% gain in the prior period.
    • The S&P Global flash manufacturing PMI fell to 49.5 in July from 51.6 in June and compared to market estimates of 51.7.
    • The S&P Global composite PMI climbed to 55.0 in July from 54.8 in the prior month.
    • The U.S. trade deficit in goods shrank to $96.84 billion in June versus a $99.37 billion gap in the earlier month.
    • Building permits increased by 3.9% to an annual rate of 1.454 million in June.

    Now Read This: Tesla To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $AZTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZTR
    $BBLG
    $DRMA
    $GOOG

    CompanyDatePrice TargetRatingAnalyst
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    1/23/2026$333.00 → $346.00Buy
    Stifel
    Alphabet Inc.
    $GOOG
    1/22/2026$400.00Outperform → Strong Buy
    Raymond James
    Alphabet Inc.
    $GOOG
    1/13/2026$350.00 → $355.00Buy
    TD Cowen
    Alphabet Inc.
    $GOOGL
    1/12/2026$268.00 → $350.00Equal Weight
    Wells Fargo
    Alphabet Inc.
    $GOOGL
    1/8/2026$370.00Neutral → Overweight
    Cantor Fitzgerald
    Alphabet Inc.
    $GOOG
    1/7/2026$330.00 → $390.00Buy
    Canaccord Genuity
    More analyst ratings

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    SEC Filings

    View All

    SEC Form DEFA14A filed by Azitra Inc

    DEFA14A - Azitra, Inc. (0001701478) (Filer)

    2/6/26 4:17:06 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Azitra Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Azitra, Inc. (0001701478) (Filer)

    2/6/26 4:15:22 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form IRANNOTICE filed by Alphabet Inc.

    IRANNOTICE - Alphabet Inc. (0001652044) (Filer)

    2/5/26 6:01:11 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Pichai Sundar sold $10,893,259 worth of Class C Capital Stock (32,500 units at $335.18), was granted 1,348,607 units of Class C Capital Stock and covered exercise/tax liability with 676,955 units of Class C Capital Stock, increasing direct ownership by 29% to 2,851,024 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/6/26 7:36:40 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    VP, Chief Accounting Officer O'Toole Amie Thuener sold $314,001 worth of Class C Capital Stock (933 units at $336.55), decreasing direct ownership by 9% to 9,916 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/3/26 6:50:39 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Director Arnold Frances sold $34,680 worth of Class C Capital Stock (102 units at $340.00), decreasing direct ownership by 0.55% to 18,307 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    1/30/26 7:52:51 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pivotal Research Group reiterated coverage on Alphabet with a new price target

    Pivotal Research Group reiterated coverage of Alphabet with a rating of Buy and set a new price target of $420.00 from $400.00 previously

    2/5/26 7:03:04 AM ET
    $GOOG
    Computer Software: Programming Data Processing
    Technology

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $360.00 from $330.00 previously

    1/26/26 10:43:23 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Stifel reiterated coverage on Alphabet A with a new price target

    Stifel reiterated coverage of Alphabet A with a rating of Buy and set a new price target of $346.00 from $333.00 previously

    1/23/26 10:18:37 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

    BRANFORD, Conn., Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced its Special Meeting scheduled for and convened on February 6, 2026, (the "Special Meeting") has been adjourned until March 6, 2026, at 11:00 a.m. Eastern Time (the "Reconvened Special Meeting") for the purpose of soliciting additional votes with respect to the proposals outlined below and described in the Company's definitive proxy statement for the Special Meeting filed with the U.S. Securities and Exchange Commission (the "SEC") on January 2, 2026 (the "Special Meeting Proxy Statement") becau

    2/6/26 4:15:00 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

    MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that it has entered into a securities purchase agreement with an institutional and accredited investor (the "Investor") for the purchase and sale of 994,537 shares (the "Shares") of the Company's common stock, $0.0001 par value (the "Common Stock") or (pre-funded warrants in-lieu thereof) together with warrants (the "Private Placement Warrants") to purchase 1,989,074 shares of Common Stock in a private placement priced at-the-market under Nasdaq rules (the "Private P

    1/29/26 4:36:12 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Dyt Info Pte. Ltd. bought $400,000 worth of shares (701,754 units at $0.57) (SEC Form 4)

    4 - NuZee, Inc. (0001527613) (Issuer)

    10/16/24 5:10:34 PM ET
    $NUZE
    Other Specialty Stores
    Consumer Discretionary

    Large owner Liu Yumei bought $797,500 worth of shares (542,517 units at $1.47) (SEC Form 4)

    4 - NuZee, Inc. (0001527613) (Issuer)

    7/23/24 5:26:55 PM ET
    $NUZE
    Other Specialty Stores
    Consumer Discretionary

    Large owner Dyt Info Pte. Ltd. bought $743,411 worth of shares (505,722 units at $1.47) (SEC Form 4)

    4 - NuZee, Inc. (0001527613) (Issuer)

    7/23/24 5:26:10 PM ET
    $NUZE
    Other Specialty Stores
    Consumer Discretionary

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces Changes to Board of Directors

    MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026. Ms. Field is the Chief Executive Officer of ISpecimen Inc., where she oversees performance improvement and the redevelopment of the proprietary software platform. Prior to serving as Chief Executive Officer she served as President, Chairman, and as an independent director. She has served as a director of LogProstyle since September 2024, as an Executive Director of Akanda Corporation since Ju

    1/23/26 4:40:27 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SOFR Academy Appoints R. Martin "Marty" Chávez as Senior Advisor

    SOFR Academy, Inc., a leading financial engineering firm, today announced the appointment of R. Martin "Marty" Chávez as Senior Advisor. Widely regarded as one of the most influential figures at the intersection of finance, technology, and data science, Mr. Chávez brings decades of leadership experience shaping modern financial markets and innovation ecosystems. He is a Partner and Vice Chairman at global investment firm Sixth Street, where he serves on the firm's Executive Committee and leads research and development initiatives focused on advanced software, artificial intelligence, and healthcare technology partnerships. Mr. Chávez also serves on the Board of Directors of Alphabet Inc. (N

    11/12/25 7:00:00 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Bone Biologics Corp

    SC 13G/A - Bone Biologics Corp (0001419554) (Subject)

    11/14/24 7:19:34 PM ET
    $BBLG
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dermata Therapeutics Inc.

    SC 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    11/14/24 5:07:13 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Azitra Inc

    SC 13G/A - Azitra, Inc. (0001701478) (Subject)

    11/14/24 12:56:51 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Financials

    Live finance-specific insights

    View All

    Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

    MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys, today announced that it will release financial results for the third quarter 2025 on November 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-274-8461 (U.S) or 1-203-51

    10/23/25 9:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

    MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, originally scheduled for August 12, 2025. The Company requires additional time to complete its valuations and for its audit firm to complete its related audit procedures. There are no current disagreements with Baker Tilly US, LLP, the Company's auditor. The Company expects to host a conference call and webcast at 9:00 AM ET on August 14, 2025 to discuss its financial results and provide a general business update. To access the live webcast, please visit the

    8/6/25 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

    MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter 2025 on August 12, 2025. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-245-3047 (U.S) or 1-203-518-9765 (international) and using the conference ID: NUWEQ2. A

    7/22/25 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care